Company / Shareholders' Equity
Bluejay Diagnostics, Inc. Shareholders' Equity History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.9M
FY2023
5-year range
$2.9M / $11.5M
FY2022-FY2023
Trend
-74.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$3M in FY2023.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, shareholders' equity decreased 74.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $2.9M | -74.9% |
| FY2022 | $11.5M | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 22, 2026